These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3910745)

  • 1. A study of the immunological effects of cimetidine in patients with lepromatous leprosy.
    Brown AE; Nelson KE; Makonkawkeyoon S; Vithayasai V; Scollard DM; Bullock WE
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):559-64. PubMed ID: 3910745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration.
    Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test.
    Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine inhibits suppressor factor production in Ethiopian lepromatous leprosy patients.
    Converse PJ; Mshana RM; Bjune GJ
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):548-53. PubMed ID: 3655466
    [No Abstract]   [Full Text] [Related]  

  • 7. The in vivo and in vitro effects of levamisole in patients with lepromatous leprosy.
    Sher R; Wadee AA; Joffe M; Kok SH; Imkamp FM; Simson IW
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):159-66. PubMed ID: 7196885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunologic status of healthy members of families with a history of leprosy.
    Price MA; Anders EM; Anders RF; Russel DA; Dennis ES
    Int J Lepr Other Mycobact Dis; 1975; 43(4):307-13. PubMed ID: 1241686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immunity in leprosy patients].
    de Arruda MS; de Arruda OS; Fleury RN; Garcia Dde O; Opromolla DV; Ura S
    Med Cutan Ibero Lat Am; 1982; 10(4):231-8. PubMed ID: 6763656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
    Silva C; Lima AO; Andrade LM; Mattos O
    Clin Exp Immunol; 1973 Sep; 15(1):87-92. PubMed ID: 4765722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro immunologic changes in 6 lepromatous leprosy or borderline leprosy patients treated with BCG alone or BCG and lepromin for 12 to 20 months, followed by BCG and antibiochemotherapy for 1 to 2 years].
    Saint-André P; Ferracci C; Baquillon G; Travi Piacentile M
    Acta Leprol; 1979; (76-77):311-4. PubMed ID: 121851
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of repeated immunological stimulation using BCG in the treatment of lepromatous leprosy. New evaluation of 13 patients].
    Ruscher H; Faye I; Languillon J; Sarrat H; Oudart JL; Carnus H
    Bull Soc Med Afr Noire Lang Fr; 1973; 18(4):470-6. PubMed ID: 4599200
    [No Abstract]   [Full Text] [Related]  

  • 15. T and B lymphocytes and blastogenesis in leprosy.
    Sharma S; Ganguly NK; Kumar B; Kaur S; Chakravarty RN
    Lepr India; 1979 Apr; 51(2):194-202. PubMed ID: 314551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cellular immunity in clinically healthy children of parents with leprosy in northern Thailand.
    Nelson KE; Speck SM; Suprasert S; Smith T
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):147-53. PubMed ID: 6539306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo controlled clinical trial of transfer factor in lepromatous leprosy.
    Faber WR; Leiker DL; Nengerman IM; Schellekens PT
    Clin Exp Immunol; 1979 Jan; 35(1):45-52. PubMed ID: 371887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of proliferative activity of lymphocytes on basal levels of lymphocytic cyclic nucleotides in lepromatous leprosy patients.
    Balybin ES; Naumov VZ
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):52-6. PubMed ID: 3011927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients].
    Minagawa F; Yoshino Y; Abe M; Saito N; Ohsawa Y; Ozawa T; Saikawa K
    Nihon Rai Gakkai Zasshi; 1989; 58(2):92-111. PubMed ID: 2697714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.